5α-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium

L. N. Thomas, R. C. Douglas, J. P. Vessey, R. Gupta, D. Fontaine, R. W. Norman, I. M. Thompson, D. A. Troyer, R. S. Rittmaster, C. B. Lazier

Research output: Contribution to journalArticlepeer-review

79 Citations (Scopus)

Fingerprint

Dive into the research topics of '5α-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium'. Together they form a unique fingerprint.

Medicine & Life Sciences